CTHRC1 is associated with BRAF(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma. Biomol Biomed [Internet]. 2024 Jul. 23 [cited 2024 Sep. 1];. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/10397